Last Updated on December 31, 2023 by The Health Master
Download the Diploma in Pharmacy Exit Examination Regulations, 2022, the link is given below: The Pharmacy Council of India (PCI) issues a letter to all pharmacy institutions and all diploma in pharmacy students regarding the exit examination for the D.Pharm. course under the “Diploma in Pharmacy Exit Examination Regulations, 2022.“
The letter states as under:
With due approval of the Ministry of Health & Family Welfare, Government of India, the PCI has notified the “Diploma in Pharmacy Exit Examination Regulations, 2022” in the Gazette of India.
It is stated that 388th Executive Committee of the PCI in its meeting held on 28-01-2023 has decided that the Exit Examination under “Diploma in Pharmacy Exit Examination Regulations, 2022” will be implemented from 2022-2023 batch of D.Pharm course.
After having passed the diploma in pharmacy, exit Examination, a candidate shall be entitled for registration as a Pharmacist subject to fulfillment of the conditions enumerated in section 32(2) of the Pharmacy Act, 1948.
Complete series Chapter 1 to 13 on India and Pharmacy Education
PCI should add vaccination subject in pharmacy syllabus
PCI directs State Pharmacy Councils to expedite transfer of registration of Pharmacists
PCI clarifies its decision to restore admission intakes
PCI: Pharma D automatically eligible for posts meant for B Pharma, D Pharma
PCI to implement Pharmacy Practice Regulations, 2015
PCI-24-02-2022-Diploma-in-Pharmacy-Exit-Examination-Regulations-2022
Pharmacy-practice-amend-Regulation-2021
PCI-dt-23-06-2021-Draft-Syllabus-for-Diploma-Course-in-Pharmacy
The-Education-Regulations-2020-for-Diploma-Course-in-Pharmacy-09-10-2020
PCI-Notification-dt-16-07-2019-Pharma-D-Automatically-Eligible-For-Posts-Meant-For-Bpharma-D-Pharma
Pharmacy-Practice-Regulations-2015
Bachelor-of-Pharmacy-Practice-Regulations-2014
Updated list of Medical Device Testing Laboratories (MDTLs)
Methotrexate may increased risk of skin cancer: Study
Takeda Pharma seeks DCGI permission for Dengue Vaccine trial
USFDA gives approval for Diclofenac Sodium Topical Solution USP
Pharma Industry announced to stop producing medicines: Pakistan
NABL alerts all Testing Laboratories regarding misrepresentation of NABL symbol
Lux level in Industry (Pharma, Cosmetics, Homeopathy & Medical Devices)
Latest IPC Alert – Indian Pharmacopoeia Commission
Latest Notifications regarding Pharmaceuticals
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
